Gregory Renza
Stock Analyst at Truist Financial
(4.79)
# 526
Out of 4,334 analysts
757
Total ratings
47.3%
Success rate
17.8%
Average return
Main Sectors:
Stocks Rated by Gregory Renza
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $778 | $638.88 | +21.78% | 11 | May 18, 2026 | |
| RVMD Revolution Medicines | Initiated Coverage: Buy | $179 | $151.56 | +18.11% | 1 | May 18, 2026 | |
| CGON CG Oncology | Maintained: Buy | n/a | $64.13 | - | 18 | May 18, 2026 | |
| NRIX Nurix Therapeutics | Maintained: Buy | n/a | $17.50 | - | 25 | May 15, 2026 | |
| ONC BeOne Medicines AG | Maintained: Buy | n/a | $310.25 | - | 13 | May 14, 2026 | |
| AGIO Agios Pharmaceuticals | Maintained: Buy | n/a | $28.14 | - | 39 | May 13, 2026 | |
| CATX Perspective Therapeutics | Maintained: Buy | n/a | $3.98 | - | 18 | May 12, 2026 | |
| GILD Gilead Sciences | Reiterated: Buy | $157 | $134.36 | +16.85% | 11 | May 8, 2026 | |
| NUVL Nuvalent | Reiterated: Buy | $140 | $102.12 | +37.09% | 6 | May 8, 2026 | |
| MNKD MannKind | Maintained: Buy | $6 | $3.38 | +77.51% | 34 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $11.31 | +156.41% | 31 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $35 | $17.24 | +103.02% | 33 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $29.10 | +123.37% | 30 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $4.72 | +154.24% | 24 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $19.57 | +94.17% | 1 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $325 → $327 | $339.30 | -3.63% | 37 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 → $7 | $4.55 | +53.85% | 8 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $6.57 | +158.75% | 15 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $22 | $21.01 | +6.33% | 3 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 | $121.99 | +14.76% | 7 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $172 → $167 | $239.83 | -30.37% | 36 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $21.10 | n/a | 57 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $3.39 | n/a | 24 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $50.15 | n/a | 31 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $1.35 | n/a | 36 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $4.24 | n/a | 23 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $6.06 | n/a | 23 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 → $46 | $0.903 | n/a | 8 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $26 | $23.35 | n/a | 31 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $0.49 | n/a | 15 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $13 | $7.98 | n/a | 14 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $38 | $51.08 | n/a | 26 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $18 | $2.28 | n/a | 24 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2,160 → $180 | $16.35 | n/a | 11 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $80 | $0.95 | n/a | 18 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 → $15 | $0.055 | n/a | 14 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $348 | $193.76 | n/a | 1 | Sep 8, 2015 |
Regeneron Pharmaceuticals
May 18, 2026
Maintained: Buy
Price Target: $778
Current: $638.88
Upside: +21.78%
Revolution Medicines
May 18, 2026
Initiated Coverage: Buy
Price Target: $179
Current: $151.56
Upside: +18.11%
CG Oncology
May 18, 2026
Maintained: Buy
Price Target: n/a
Current: $64.13
Upside: -
Nurix Therapeutics
May 15, 2026
Maintained: Buy
Price Target: n/a
Current: $17.50
Upside: -
BeOne Medicines AG
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $310.25
Upside: -
Agios Pharmaceuticals
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $28.14
Upside: -
Perspective Therapeutics
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $3.98
Upside: -
Gilead Sciences
May 8, 2026
Reiterated: Buy
Price Target: $157
Current: $134.36
Upside: +16.85%
Nuvalent
May 8, 2026
Reiterated: Buy
Price Target: $140
Current: $102.12
Upside: +37.09%
MannKind
May 7, 2026
Maintained: Buy
Price Target: $6
Current: $3.38
Upside: +77.51%
May 7, 2026
Reiterated: Buy
Price Target: $29
Current: $11.31
Upside: +156.41%
May 6, 2026
Maintained: Buy
Price Target: $33 → $35
Current: $17.24
Upside: +103.02%
May 6, 2026
Reiterated: Buy
Price Target: $65
Current: $29.10
Upside: +123.37%
May 5, 2026
Maintained: Buy
Price Target: $12
Current: $4.72
Upside: +154.24%
May 4, 2026
Reiterated: Buy
Price Target: $38
Current: $19.57
Upside: +94.17%
May 1, 2026
Maintained: Hold
Price Target: $325 → $327
Current: $339.30
Upside: -3.63%
May 1, 2026
Maintained: Hold
Price Target: $8 → $7
Current: $4.55
Upside: +53.85%
Apr 28, 2026
Reiterated: Buy
Price Target: $17
Current: $6.57
Upside: +158.75%
Apr 24, 2026
Maintained: Buy
Price Target: $51 → $22
Current: $21.01
Upside: +6.33%
Mar 24, 2026
Reiterated: Buy
Price Target: $140
Current: $121.99
Upside: +14.76%
Jul 7, 2025
Maintained: Buy
Price Target: $172 → $167
Current: $239.83
Upside: -30.37%
May 19, 2025
Reiterated: Buy
Price Target: $26
Current: $21.10
Upside: n/a
May 14, 2025
Maintained: Buy
Price Target: $8
Current: $3.39
Upside: n/a
May 13, 2025
Maintained: Buy
Price Target: $40
Current: $50.15
Upside: n/a
May 13, 2025
Maintained: Hold
Price Target: $5
Current: $1.35
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: $16
Current: $4.24
Upside: n/a
May 13, 2025
Maintained: Hold
Price Target: $20
Current: $6.06
Upside: n/a
May 12, 2025
Maintained: Buy
Price Target: $48 → $46
Current: $0.903
Upside: n/a
May 8, 2025
Maintained: Hold
Price Target: $26
Current: $23.35
Upside: n/a
May 7, 2025
Maintained: Buy
Price Target: $16
Current: $0.49
Upside: n/a
May 6, 2025
Maintained: Buy
Price Target: $12 → $13
Current: $7.98
Upside: n/a
May 6, 2025
Maintained: Hold
Price Target: $38
Current: $51.08
Upside: n/a
Nov 10, 2023
Maintained: Buy
Price Target: $23 → $18
Current: $2.28
Upside: n/a
Jun 26, 2023
Downgraded: Hold
Price Target: $2,160 → $180
Current: $16.35
Upside: n/a
Mar 16, 2022
Maintained: Hold
Price Target: $5 → $80
Current: $0.95
Upside: n/a
Nov 12, 2021
Maintained: Hold
Price Target: $1 → $15
Current: $0.055
Upside: n/a
Sep 8, 2015
Rated: Buy
Price Target: $348
Current: $193.76
Upside: n/a